State of the Journal
Acknowledgment of Reviewers
Indolent Lung Cancers—Time for a Paradigm Shift
Role of Chromosome 3q Amplification in Lung Cancer
Validation Study of the Proposed IASLC Staging Revisions of the T4 and M Non-small Cell Lung Cancer Descriptors Using Data from 23,583 Patients in the California Cancer Registry
Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity
Ethnic Differences in the Management of Lung Cancer in New Zealand
The Yield of Endoscopic Ultrasound in Lung Cancer Staging: Does Lymph Node Size Matter?
Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study
Thymic Carcinoma: 30 Cases at a Single Institution
Pathologic Radioresponse of Preoperatively Irradiated Invasive Thymomas
Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy
A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery
What to do with “Surprise” N2?
EGFR Inhibitors as First-Line Therapy in Advanced Non-small Cell Lung Cancer
Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutations in Three Siblings
Increased Vascular-Endothelial Growth Factor (VEGF) Tumor Expression and Response to Epidermal Growth Factor Receptor (EGF-R) Inhibitor Erlotinib in Non-small Cell Lung Cancer (NSCLC)
The IASLC Lung Cancer Staging Project: Revision Proposal of Pleural Effusion and Controlateral Nodule Staging
Reply to the Letter to the Editor Entitled The IASLC Lung Cancer Staging Project: Revision Proposal of Pleural Effusion and Contralateral Nodule Staging, by V. Barbieri, P. Tassone, and P. Tagliaferri
IASLC Lung Cancer Staging Project—A Radiologist Perspective
Reply to “Cancer Staging Correspondence 2”
Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis
Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis
ERRATUM
Meeting Announcements